NEW YORK, NY / ACCESSWIRE / February 25, 2021 / Axonics Modulation Technologies, Inc. (NASDAQ:AXNX) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on ...

The following is a summary of “A prospective feasibility study to differentiate sacral neuromodulation lead electrode configurations using motor and sensory thresholds and locations of sensation,” ...

Medtronic Plc and Axonics Modulation Technologies Inc. have agreed to end a case in which Axonics was cleared at trial of allegations it infringed patents for an implant device used to treat ...

IRVINE, Calif. (AP) — IRVINE, Calif. (AP) — Axonics Modulation Technologies Inc. (AXNX) on Thursday reported a third-quarter loss of $21,000, after reporting a profit in the same period a year earlier ...

IRVINE, Calif. (AP) — IRVINE, Calif. (AP) — Axonics Modulation Technologies Inc. (AXNX) on Thursday reported second-quarter net income of $6.9 million, after reporting a loss in the same period a year ...

IRVINE, Calif. (AP) — IRVINE, Calif. (AP) — Axonics Modulation Technologies Inc. (AXNX) on Tuesday reported a loss of $19.1 million in its first quarter. On a per-share basis, the Irvine, ...

The Federal Trade Commission (FTC) is taking a closer look at Boston Scientific’s $3.7 billion proposal to acquire neuromodulation developer Axonics, a move that could push back the closing of the ...